EFFECT OF COMBINATION THERAPY WITHFOSINOPRIL AND MELDONIUM ON THE INDICES OF 48-HOUR MONITORING OF BLOOD PRESSURE AND MYOCARDIUM GEOMETRY IN HEMODIALYSIS PATIENTS WITH CHRONIC HEART FAILURE
Abstract
Despite medical advances, cardiovascular complications continue to dominate in patients treated with hemodialysis. Therefore, the search for new methods of diagnosis and treatment is advisable.
The objective of our research was to study the effectiveness of combination therapy with Fosinopril and Meldonium in patients with stage У chronic kidney disease (CKD) with the signs of chronic heart failure.
Materials and methods of the research: 60 patients with stage У CKD were examined and treated. They were on out-patient treatment with program hemodialysis at the Department of extracorporal methods ofdetoxification and chronic dialysis.
Results. Significant decrease in left ventricular mass (LVM) by 17.20% (p<0.001) and LVM index by 13.40% (p<0.001) was detected in patients treated with combination of Fosinopril and Meldonium Dehydrate in addition to background therapy. Regression of both concentric and eccentric left ventricular hypertrophy equally occurred under the influence of combination therapy constituting 53.6% vs. 40.2% and 33.4% vs. 26.6%, respectively. The variability of systolic blood pressure (SBP) was found to decrease significantly by 36.02% (p<0.001). The survival analysis provided an opportunity to determine a reliable difference between the group treated with background therapy and the addition ofa combination of two drugs.
Conclusions. The addition of Fosinopril and Mel- donium to the background dialysis therapy significantly improved the structural and geometric cardiac indices, positively affected the variability of SBP, increased the prognosis of cumulative survival compared to the background therapy.
Downloads
References
Визир В. А. Перспективы применения мил- дроната у больных сердечной недостаточностью, развившейся вследствие ишемической болезни сердца / В.А. Визир, А.Е. Березин // Артериальная гипертензия. – 2012. – № 4. – С. 49-54.
Візір В.А. Вплив кандесартану на показники добового артеріального тиску у пацієнтів з хронічною хворобою нирок на програмному гемодіалізі / В. А. Візір, О. Г. Овська, А. С. Садомов // Український журнал нефрології та діалізу. – 2014. - № 3. - С. 27-34.
Головач І.Ю. Використання коректорів метаболізму на основі мельдонію дигідрату: сучасний підхід у комбінованій терапії ішемічних захворювань серця / І.Ю. Головач, О.М. Авраменко // Ліки України. - 2011. - № 8. - С. 68-72.
Клинический опыт применения мельдония у больных ишемической болезнью сердца, ассоциированной с артериальной гипертензией / В.В. Буряк, Е.Г. Овская, А.В. Насоненко [и др.] // Молодий вчений. - 2014. - № 1. - С. 202205.
Оценка антиангинальной эффективности мельдония (Тризипина) у пациентов со стабильной ишемической болезнью сердца и стенокардией напряжения / М.И. Лутай, А.Ф. Лысенко, В.В. Товстуха [и др.] // Український медичний часопис. - 2014. - № 4. - С. 50-53.
Токаренко О.О. Показники добового моніто- рування артеріального тиску та їх предикторна здатність у хворих на гіпертензивну нефропатію / О.О. Токаренко // Зб. наук. праць спів- робіт. НМАПО імені П.Л.Шупика. - 2015. - № 2. - С. 361-368.
Черняга-Ройко У.П. Варіабельність артеріального тиску - стратегічна мішень комбінованої антигіпертензивної терапії чи міф експериментальних досліджень? / У.П. Черняга-Ройко, М.С. Сороківський // Здоров’я України. - 2012. - № 1. - С. 1-3.11.
Allon M. Evidence-Based Cardiology in Hemodialysis Patients / M. Allon // Journal of the American Society of Nephrology. – 2013. – Vol. 24. – P.1934-1943.
Arterial stiffness and pulse pressure in CKD and ESRD / Marie Briet, Pierre Boutouyrie, Ste phane Laurent [et al.] // Kidney International. - 2012. - Vol. 82. - P. 388-400.
Blood pressure levels and mortality risk among hemodialysis patients in the Dialysis Outcomes and Practice Patterns Study / Bruce M. Robinson, Lin Tong, Jinyao Zhang [et al.] // Kidney International. - 2012. - Vol. 82 - P. 570-580.
Blood pressure stability in hemodialysis patients confers a survival advantage: results from a large retrospective cohort study / Jochen G. Raimann, Len A. Usvyat, Stephan Thijssen [et al.] // Kidney International. - 2012. - Vol. 81. - С. 548-558.
Cardiovascular Disease Risk Factors and Left Ventricular Hypertrophy in Girls and Boys With CKD / Rebecca L. Ruebner, Derek Ng, Mark Mitsnefes [et al.] // Clin J Am Soc Nephrol. - 2016. - Vol. 11. - Р. 1-7.
Comparison of the risk of de novo cardiovascular disease between hemodialysis and peritoneal dialysis in patients with end stage renal disease / IKuan Wang ChiYu, Lu ChengLi, Lin ChihChia Liang [et al.] // International Journal of Cardiology. - 2016. - Vol. 218. - P. 219-224.
End-stage renal disease patients on chronic maintenance hemodialysis in a hospitalized acute heart failure cohort: Prevalence, clinical characteristics, therapeutic options, and mortality / Yuichiro Minami, Katsuya Kajimoto, Naoki Sato [et al.] // International Journal of Cardiology. - 2016. - Vol. 224. - P. 267-270.
Interdialytic weight gain, systolic blood pressure, serum albumin, and C-reactive protein levels change in chronic dialysis patients prior to death / Len A. Usvyat, Claudia Barth, Inga Bayh [et al.] // Kidney International. - 2013. - Vol. 84. - P. 149-157.
Longjian Liu. Using multivariate quantile regression analysis to explore cardiovascular risk differences in subjects with chronic kidney disease by race and ethnicity: Findings from the U.S. Chronic Renal Insufficiency Cohort Study / Liu Longjian // International Cardiovascular Forum Journal. - Vol. 2. - 2015. - P. 20-26.
Masked Hypertension and Elevated Nighttime Blood Pressure in CKD: Prevalence and Association with Target Organ Damage / Paul E. Drawz, Arnold B. Alper, Amanda H. Anderson [et al.] // Clin J Am Soc Nephrol. - 2016. - Vol. 11. - Р. 642-652.
Multiphasic effects of blood pressure on survival in hemodialysis patients / Thierry Hannedouche, Hubert Roth, Thierry Krummel [et al.] // Kidney International. - 2016. - Vol. 90. - С. 674-684.
Pre- and Postdialysis Blood Pressures Are Imprecise Estimates of Interdialytic Ambulatory Blood Pressure / Rajiv Agarwal, Aldo J. Peixoto, Sergio F.F. Santos [et al.] and other] // Clin J Am Soc Nephrol. - 2006. - Vol. 1. - Р. 389-398.
Prevention of cardiovascular events in end-stage renal disease: Results of a randomized trial of fosinopril and implications for future studies / F. Zannad, M. Kessler, P. Lehert [et al.] // International Society of Nephrology. - 2006. - Vol. 70. - P. 1318-1324.
Proposal for a Functional Classification System of Heart Failure in Patients With End-Stage Renal Disease Proceedings of the Acute Dialysis Quality Initiative (ADQI) XI Workgroup / Lakhmir S. Chawla, Charles A. Herzog, Maria Rosa Costanzo [et al.] // Journal of the American College of Cardiology. - 2014. - Vol. 13. - Р. 1246-1252.
Sudden cardiac death and chronic kidney disease: from pathophysiology to treatment strategies / Di Lullo, L. Rivera, R. Barbera [et al.] // International Journal of Cardiology. – 2016. – Vol. 217. - P. 16-27.
Yoshihiro Taniyama. Management of hypertension for patients undergoing dialysis therapy / Taniyama Yoshihiro // Renal Replacement Therapy. - 2016. - Vol. 21. - P. 1-6.
